Journal of Cancer Research and Experimental Oncology
Subscribe to JCREO
Full Name*
Email Address*

Article Number - 98D395841018

Vol.5(1), pp. 1-7 , November 2013
DOI: 10.5897/JCREO2013.0101
ISSN: 2141-2243

Full Length Research Paper

Mapping Angiogenic Cells CD31 (PECAM1) and CD45 in PCa and BPH Biopsies

Adegun P.T
  • Adegun P.T
  • Ekiti State University Teaching Hospital, Ado-Ekiti, Department of Urology, College of Medicine.
  • Google Scholar
Ogundele O.M
  • Ogundele O.M
  • Afe Babalola University, College of Medicine and Health Sciences, Department of Anatomy.
  • Google Scholar
Falode D.T
  • Falode D.T
  • Blood and Cancer Centre, American Hospitals and Resorts, Lagos, Nigeria.
  • Google Scholar
Taiwo O.J
  • Taiwo O.J
  • Ekiti State University Teaching Hospital, Ado-Ekiti, Department of Histopathology, College of Medicine.
  • Google Scholar
Ajonijebu D.C
  • Ajonijebu D.C
  • Afe Babalola University, College of Medicine and Health Sciences Department of Physiology, College II.
  • Google Scholar
Omoaghe A.O
  • Omoaghe A.O
  • Afe Babalola University, College of Medicine and Health Sciences Department of Physiology, College II.
  • Google Scholar
Kobomoje O.S
  • Kobomoje O.S
  • Afe Babalola University, College of Sciences, Department of Biological Sciences, College.
  • Google Scholar

 Accepted: 02 October 2013  Published: 30 November 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Molecular characterization of PCa and BPH using the angiogenic tissue markers CD31 and CD45 to differentiate between the two major types of prostate gland disorders is investigated. 8 clinically characterized biopsies were analyzed at the Histopathology Laboratory of the Ekiti State University Teaching Hospital; the tissue sections were processed for antigen retrieval and were labeled with anti-CD45 and anti-CD31 to map the location of angiogenic cells and vascularization in BPH and PCa. The results showed that PCa biopsies expressed embryonic stem cell status of CD31+/CD45+, while BPH showed CD31-/CD45+. This suggests the presence of migrating blood cells (vascularization) in PCa and the absence of such in BPH. It also confirms the role of platelets in endothelial activation that can result to cell proliferation and apoptosis in the prostate gland of either BPH or PCa diagnosed patients.
Key words: CD31, CD45, Prostate, Endothelioma, Vascularization, Angiogenesis

Blann AD, Balakrishnan B, Shantsila E, Ryan P, Lip GY (2011). Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers. Prostate. 71(10):1047-1053.
Brennen WN, Chen S, Denmeade SR, Isaacs JT (2013). Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer. Oncotarget. 4(1):106-117.
Carvalho FL, Simons BW, Antonarakis ES, Rasheed Z, Douglas N, Villegas D, Matsui W, Berman DM (2013). Tumorigenic potential
of circulating prostate tumor cells. Oncotarget. 4(3):413-421.
Chen CL, Mahalingam D, Osmulski P, Jadhav RR, Wang CM, Leach RJ, Chang TC, Weitman SD, Kumar AP, Sun L, Gaczynska ME, Thompson IM, Huang TH (2012). Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate. 73(8):813-826.
Cooper CR, Bhatia JK, Muenchen HJ, McLean L, Hayasaka S, Taylor J, Poncza PJ, Pienta KJ (2002). The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines. Clin. Exp. Metastasis. 19(1):25-33.
Gravina GL, Mancini A, Ranieri G, Di Pasquale B, Marampon F, Di Clemente L, Ricevuto E, Festuccia C (2013). Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. J Oncol. 42(6):2116-2122.
Jin R, Sterling JA, Edwards JR, Degraff DJ, Lee C, Park SI, Matusik RJ (2013). Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone. PLoS One. 8(4):e60983.
Jones ML, Siddiqui J, Pienta KJ, Getzenberg RH (2013). Circulating fibroblast-like cells in men with metastatic prostate cancer. Prostate. 73(2):176-181.
Kyprianou N, Tu H, Jacobs SC (1996). Apoptotic versus proliferative activities in Human Benign prostatic hyperplesia. Human Pathol. 27(7):668-675.
Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON (2007). Isolation and functional characterization of murine prostate stem cells. Proc. Nat. Acad. Sci. 104(1):181-186.
Lazar DC, Cho EH, Luttgen MS, Metzner TJ, Uson ML, Torrey M, Gross ME, Kuhn P (2012). Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line. Phys Biol. 9(1):016002.
Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S (2013). Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One. 8(1):e55319.
Mackern OJP, Breser ML, Nu-ez N, Maccioni M, Rodríguez N, Wantia N, Ertl T, Miethke T, Rivero VE (2011). Chemokine response induced by Chlamydia trachomatis in prostate derived CD45+ and CD45- cells. Reproduction. 142(3):427-437.
Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, Kharbanda S, Kalluri R (2001). Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J. Biol. Chem. 276(18):15240-15248.
Morelli A, Comeglio P, Filippi S, Sarchielli E, Vignozzi L, Maneschi E, Cellai I, Gacci M, Lenzi A, Vannelli GB, Maggi M (2013). Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit. Prostate. 73(4):428-441.
Poveda A, Kaye SB, McCormack R, Wang S, Parekh T, Ricci D, Lebedinsky CA, Tercero JC, Zintl P, Monk BJ (2011). Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer. Gynecol. Oncol. 122(3):567-572.
Ribeiro R, Monteiro C, Silvestre R, Castela A, Coutinho H, Fraga A, Príncipe P, Lobato C, Costa C, Cordeiro-da-Silva A, Lopes JM, Lopes C, Medeiros R (2012). Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Exp. Biol. Med. 237(10):1155-1162.
Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, Raco A, Salvati M, De Maria R, Russo MA (2011). Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J. Neuroinflammation. 13:8-32.
Ting H, Deep G, Agarwal R (2013). Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer. AAPS J. 15(3):707-716.
Wong CK, Namdarian B, Chua J, Chin X, Speirs R, Nguyen T, Fankhauser M, Pedersen J, Costello AJ, Corcoran NM, Hovens CM (2012). Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy. Br. J. Cancer. 107(9):1564-1573.
Zhang ZZ, Gong YY, Shi YH, Zhang W, Qin XH, Wu XW (2012). Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.Neurosci. 24:282-293.


APA (2013). Mapping Angiogenic Cells CD31 (PECAM1) and CD45 in PCa and BPH Biopsies. Journal of Cancer Research and Experimental Oncology, 5(1), 1-7.
Chicago Adegun P.T, Ogundele O.M, Falode D.T, Taiwo O.J, Ajonijebu D.C, Omoaghe A.O and Kobomoje O.S. "Mapping Angiogenic Cells CD31 (PECAM1) and CD45 in PCa and BPH Biopsies." Journal of Cancer Research and Experimental Oncology 5, no. 1 (2013): 1-7.
MLA Adegun P.T, et al. "Mapping Angiogenic Cells CD31 (PECAM1) and CD45 in PCa and BPH Biopsies." Journal of Cancer Research and Experimental Oncology 5.1 (2013): 1-7.
DOI 10.5897/JCREO2013.0101

Subscription Form